Zhongchao (ZCMD) Debt to Equity (2018 - 2024)

Zhongchao (ZCMD) reported Debt to Equity of $0.02 for Q4 2024, down 13.5% year-over-year from $0.03 in Q1 2024, and down 13.5% on a QoQ basis from $0.03 in Q4 2023.

Zhongchao (ZCMD) has 4 years of Debt to Equity data on file, last reported at $0.02 in Q4 2024.

  • Quarterly Debt to Equity fell 13.5% year-over-year to $0.02 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $0.02 (down 13.5% YoY) and the FY2024 annual result came in at $0.02, down 13.5% from the prior year.
  • Debt to Equity fell to $0.02 in Q4 2024 per ZCMD's latest filing, from $0.03 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.03 in Q4 2023 and bottomed at $0.02 in Q4 2022.
  • The 3-year median for Debt to Equity is $0.02 (2024), against an average of $0.02.
  • The widest annual swing landed in 2023, when Debt to Equity climbed 16.15%; it then fell 13.5% in 2024.
  • Tracing ZCMD's Debt to Equity over 3 years: stood at $0.02 in 2022, then rose by 16.15% to $0.03 in 2023, then fell by 13.5% to $0.02 in 2024.
  • Per Business Quant, the three latest ZCMD Debt to Equity figures stand at $0.02 (Q4 2024), $0.03 (Q4 2023), and $0.02 (Q4 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 1.26
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.46
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.37
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Zhongchao - - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 0.02
Dec 31, 2023 0.03
Dec 31, 2022 0.02
Dec 31, 2018 0.06